CMS Open Payments · Program Year 2024
Rti Surgical, Inc
Rti Surgical, Inc reported $1,438,745.77 across General Payments, Research, and Ownership to 821 physicians and teaching hospitals across 830 transactions.
- $1.4M Above-median payer
- All-tracks total
- 830 Above-median volume
- Transactions
- 821 Above-median reach
- Recipients
- +$720.9K
- General Payments vs PY2023
Rti Surgical, Inc reported $1,438,745.77 across all CMS Open Payments tracks (General + Research + Ownership) to 821 physicians and teaching hospitals in Program Year 2024 - ranking #534 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,400,890.77, averaging $1.8K per recipient.
How Rti Surgical, Inc's $1.4M all-tracks total breaks down
Rti Surgical, Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
30/100
Total payments
F
23/100
Transaction volume
F
16/100
Physician reach
F
16/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer rti-surgical-inc Rti Surgical, Inc
$1.4M · #534/1,925 · 0.0% industry · PY2024
- TOT $1.4M
- RANK #534
- SHARE 0.0%
- TXN 830
- RCP 821
- CAT 5
- GEN $1.4M
- ΔGEN +$720.9K
- TOP1 20.4%
- PY 2024
Volume peers
Nearest volume peer: Esteve Pharmaceuticals LLC ($1.4M)
Rti Surgical, Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Rti Surgical, Inc's CMS-reported General Payments increased by $720.9K (+106.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: RTI SURGICAL, INCPY2023: RTI SURGICAL, INCPY2024: RTI SURGICAL, INC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $679,971.05
- PY2024
- $1,400,890.77
What the Data Shows for Rti Surgical, Inc
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Rti Surgical, Inc, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 5-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $667.9K, accounting for 47.7% of this company's General Payments and 93 transactions.
General Payment Breakdown by Type
Across 5 types of general payments, Rti Surgical, Inc's largest category was "Consulting Fee" at $667.9K - 47.7% of General Payments.
Rti Surgical, Inc reports 5 general-payment categories - the top three are Consulting Fee (47.7%), Royalty or License (35.4%), and Honoraria (11.3%). The remaining 2 categories make up 5.6% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Rti Surgical, Inc divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $667.9K | 93 | 47.7% |
| Royalty or License | $496.1K | 28 | 35.4% |
| Honoraria | $158.4K | 129 | 11.3% |
| Food and Beverage | $48.0K | 570 | 3.4% |
| Education | $30.4K | 1 | 2.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $827,629.27 (59.1%) of $1,400,890.77 in this company's General Payments records across 426 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Rti Surgical, Inc
The five named recipients with the highest reported General Payments from this company
- 1
Suhail Khuzema Kanchwala
$286,200.00 across 22 reported transactions
- 2
David N Armstrong
$251,306.34 across 8 reported transactions
- 3
Marek Fried
$146,040.00 across 12 reported transactions
- 4
Luther Hamilton Holton III
$94,869.04 across 13 reported transactions
- 5
Terence Michael Myckatyn
$49,213.89 across 7 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Rti Surgical, Inc ranks #534 of 1,925 by total payments (top 28% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,038 of 1,838 by HHI (bottom 44% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Limacorporate S.p.A. : $183.8K total payments, HHI 995
- CLR Medical, Inc. : $10.8K total payments, HHI 991
- Tactile Systems Technology Inc : $810.5K total payments, HHI 989
- Vivus LLC : $184.4K total payments, HHI 986
- Geron Corporation : $91.2K total payments, HHI 985
- Macrogenics, Inc. : $1.1K total payments, HHI 985
- Rti Surgical, Inc (this company) : $1.4M total payments, HHI 982
- OssDsign Incorporated : $88.5K total payments, HHI 981
- Mf Med : $630.54 total payments, HHI 979
- B. Braun Medical Inc. : $221.2K total payments, HHI 975
- Vioptix Inc : $4.7K total payments, HHI 971
- Bolton Medical Inc : $2.2M total payments, HHI 970
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Rti Surgical, Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Rti Surgical, Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Rti Surgical, Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
ANI Pharmaceuticals, Inc.
Aurora Spine, Inc.
Seres Therapeutics, Inc.
Tactile Systems Technology Inc
FUJIFILM Healthcare Americas Corporation
Put this to use
Rti Surgical, Inc ranks #534 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Rti Surgical, Inc sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Rti Surgical, Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.